APA (7th ed.) Citation

NN, L., B, L., TJ, Q., SQ, Q., LJ, P., M, J., . . . ZF, X. (2026). [External validation and incremental value assessment of the RR6 prognostic model in Chinese myelofibrosis patients treated with ruxolitinib: Focusing on overall survival]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 47(1), 50. https://doi.org/10.3760/cma.j.cn121090-20250418-00188

Chicago Style (17th ed.) Citation

NN, Liu, et al. "[External Validation and Incremental Value Assessment of the RR6 Prognostic Model in Chinese Myelofibrosis Patients Treated with Ruxolitinib: Focusing on Overall Survival]." Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi 47, no. 1 (2026): 50. https://doi.org/10.3760/cma.j.cn121090-20250418-00188.

MLA (9th ed.) Citation

NN, Liu, et al. "[External Validation and Incremental Value Assessment of the RR6 Prognostic Model in Chinese Myelofibrosis Patients Treated with Ruxolitinib: Focusing on Overall Survival]." Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, vol. 47, no. 1, 2026, p. 50, https://doi.org/10.3760/cma.j.cn121090-20250418-00188.